FGP
EOLS icon

Freestone Grove Partners’s Evolus EOLS Stock Holding History

Freestone Grove Partners’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,367
Closed -$105K – 760
2025
Q2 		$105K Hold
11,367
– – ﹤0.01% 644
2025
Q1 		$137K Sell
11,367
-1,314
-10% -$17.2K ﹤0.01% 554
2024
Q4 		$140K Buy
+12,681
New +$178K ﹤0.01% 551

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Freestone Grove Partners's EOLS Position: Q3 2025 in Review

Freestone Grove Partners sold out of Evolus (EOLS) in Q3 2025, closing a stake of 11,367 shares — an estimated $105K sold.

Freestone Grove Partners first reported a position in EOLS in Q4 2024 and held it in 3 quarters. The position peaked at $140K in Q4 2024. 160 funds tracked by Wall St. Rank hold EOLS as of Q3 2025.

  • Freestone Grove Partners reported no remaining Evolus position as of Q3 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 11,367 Evolus shares in Q3 2025, an estimated $105K.
  • Freestone Grove Partners first reported a position in Evolus in Q4 2024 and held it in 3 quarters.
  • Freestone Grove Partners's Evolus position peaked at $140K in Q4 2024.
  • 160 funds tracked by Wall St. Rank held Evolus as of Q3 2025.

Based on Freestone Grove Partners's 13F filing for Q3 2025, filed 14 Nov 2025.